The FDA has authorized the launch of an early-stage trial testing a CAR T-cell therapy for people with hard-to-treat ...
Australia's only dedicated stem cell resource for multiple sclerosis (MS) research has expanded significantly this year, ...
For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...
AHSCT resets the immune system in highly active RRMS after high-efficacy drugs fail, delivering higher NEDA, fewer relapses, and durable function gains. When high-efficacy drugs stop holding relapsing ...
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Tr1X, a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered type 1 regulatory (Tr1 Treg) and CAR-Tr1 Treg cell ...
DISABLED ENTREPRENEUR UK on MSN
Natalizumab for multiple sclerosis: Understanding treatment options
Natalizumab is a highly effective treatment for active multiple sclerosis, but what are the risks of JC virus and PML? We ...
Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), likely contributing to the persistent inflammation characteristic of the ...
Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), likely contributing to the persistent inflammation characteristic of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results